Skip to content
GenoLensGenoLens

GALC

Chr 14q31.3

galactosylceramidase

MANE:
ENST00000261304.7

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Adult onset hereditary spastic paraplegia

    BIALLELIC, autosomal or pseudoautosomal
  • Adult onset leukodystrophy

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset hereditary spastic paraplegia

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary neuropathy

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary neuropathy or pain disorder

    BIALLELIC, autosomal or pseudoautosomal

+10 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • Krabbe disease

    0.86
  • hereditary disease

    0.51
  • inflammatory bowel disease

    0.43
  • Crohn disease

    0.42
  • spastic ataxia

    0.41
  • Parkinson disease

    0.40
  • adult Krabbe disease

    0.39
  • late-infantile/juvenile Krabbe disease

    0.38
  • infantile Krabbe disease

    0.38
  • ulcerative colitis

    0.36

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Galactocerebrosidase

Hydrolyzes the galactose ester bonds of glycolipids such as galactosylceramide and galactosylsphingosine (PubMed:8281145, PubMed:8399327). Enzyme with very low activity responsible for the lysosomal catabolism of galactosylceramide, a major lipid in myelin, kidney and epithelial cells of small intestine and colon (PubMed:8281145, PubMed:8399327)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.